Gal‐3 modulates diverse pathological processes such as cardiac ischemia–reperfusion injury and ultraviolet‐induced skin inflammation by influencing the JNK pathway and phosphorylation of p38, respectively, while in neuroblastoma, Gal‐3BP activates IL‐6 production in mesenchymal stem cells through the ERK signaling pathway.8, 9, 10. The gene discussed is IL6; the disease is neuroblastoma.